Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

InforSense® Announces Conference Series

Published: Tuesday, November 14, 2006
Last Updated: Tuesday, November 14, 2006
Bookmark and Share
The InforSense Users Conference will provide opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.

InforSense Ltd. has announced three upcoming InforSense-hosted conferences. The Statistical Genetics Workshop, co-chaired by Dr Jean-Pierre Kocher, Bioinformatics Core Director at the Mayo Clinic and Jonathan Sheldon, CSO at InforSense, will bring together thought leaders and practitioners in the Statistical Genetics arena to share case studies and best practices in this evolving field - from data cleaning to advanced statistical methods. 

The Agenda features presentations from key players in the field and an open panel discussion. The agenda, list of registered speakers and registration form are available online
 
The InforSense Users Conference will provide you with the opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.

Contributions from Keynote Speakers, InforSense KDE users, Partners and InforSense Product Specialists will help you to maximize the value of InforSense technology in your organization.

Register online to reserve your place and receive further information on the Users Conference.
 
The Translational Medicine Symposium will bring together thought leaders and practitioners in the Translational Medicine arena - from pharmaceutical and biotechnology organizations, biomedical research institutes and academia - to explore current trends, opportunities and unmet needs.

The Symposium will provide an opportunity for key players in the field to present the current practices through invited scientific and technical presentations.

It will also provide a forum to discuss the requirements for informatics between and across the many different disciplines that comprise Translational Medicine.

For the agenda, list of speakers and registration form visit Company website.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

InforSense Partners with U.K.’s Leading Institutions to Combat Alzheimer’s Disease
Translational research solution to help accelerate early diagnosis and personalized medicine treatments.
Wednesday, December 03, 2008
InforSense GenSense Achieves GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform
Affymetrix has become a member of InforSense’s Open Workflow Partner Network joining over 40 other partners in the program.
Tuesday, August 07, 2007
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!